FY2025 · ended Dec 31, 2025 · Revenue $1.27B, -5.0% YoY · Filed Feb 27, 2026
Curaleaf Holdings, Inc. (CURLF) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.3 billion and a net loss of $231.1 million. Free cash flow was $74.3 million. As of Sep 30, 2026 it held $92.4 million in cash and investments and $928.5 million in total debt.
Revenue
$1.27B
-5.0% vs prior year
Net income
$-231.07M
-7.3% vs prior year
Operating cash flow
$137.71M
-15.8% vs prior year
Free cash flow
$74.27M
+4.3% vs prior year
EPS
$-0.35
-9.4% vs prior year
Dividend per share
None
Shares outstanding
750.06M
+2.2% vs prior year
Net cash
$-836.09M
as of Sep 30, 2026
Operating margin
2.0%
FY 2025
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CURLF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Stamford, CT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1756770
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B |
| Operating income | $25.4M | $24.7M | $42.9M | $65.0M | — |
| Net income | -$231.1M | -$215.4M | -$281.2M | -$370.1M | — |
| Diluted EPS | -$0.35 | -$0.32 | -$0.39 | -$0.52 | — |
| Operating cash flow | $137.7M | $163.6M | $75.3M | $46.4M | -$34.0M |
| Free cash flow | $74.3M | $71.2M | $9.8M | -$88.2M | -$205.9M |
| Total assets | $2.8B | $2.9B | $3.1B | $3.4B | $3.1B |
| Total liabilities | $2.0B | $2.0B | $1.9B | $2.0B | $1.4B |
| Stockholders' equity | $756.4M | $861.2M | $1.1B | $1.3B | — |
| Cash and investments | $101.6M | $107.2M | $94.3M | $166.0M | $299.3M |
| Total debt | $827.0M | $853.8M | $883.5M | $928.7M | $755.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Other events
|
Oct 28, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Other events
|
Oct 19, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Other events
|
Oct 6, 2026 | Oct 6, 2026 |
All 226 Curaleaf Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.